Skip to main content

Table 2 Base line characteristics of HIV positive children at ART initiation in public health facilities of Bahir Dar city, Northwest Ethiopia, 2021(N = 459)

From: Incidence and predictors of initial antiretroviral therapy regimen change among children in public health facilities of Bahir Dar City, Northwest Ethiopia, 2021: multicenter retrospective follow-up study

Variables

Categories

Censored, n (%)

Initial regimen change, n (%)

Opportunistic infection

Yes

73(29.92)

171(70.08)

No

71(33.02)

144(66.98)

Functional status)

No or mild limitation

121(31.84)

259(68.16)

Moderate or severe limitation

23(29.11)

56(70.89)

CD4 count

≤200 cells/m3

19(35.19)

35(64.81)

> 200 cells/m3

125(30.86|)

280(69.14)

Weight

≤20 kg

88(32.47)

183(67.53)

> 20 kg

56(29.79)

132(70.21)

Serum hemoglobin

≤11 mg/dl

26(40.63)

38(59.38)

> 11 mg/dl

118(29.87)

277(70.13)

History tuberculosis

Yes

11(21.15)

41(78.85)

No

133(32.68)

274(67.32)

ART regimen

TDF based

12(30.00)

28(70.00)

ABC based

35(60.34)

23(39.66)

AZT based

81(30.34)

186(69.66)

D4T based

16(17.02)

78(82.98)

Deterioration of WHO clinical stage

Yes

2(25.00)

6(75.00)

No

142(31.49)

309(68.51)

Adherence

Good

129(36.54)

224(63.46)

Poor/fair

15(14.15)

91(85.85)

ART regimens

NVP based

62 (24.41)

192(75.59)

EFV based

55 (31.61)

119(68.39)

DTG based

5 (83.33)

1(16.67)

LPVr based

22(88.00)

3(12.00)

Nutritional status

Severe and moderate under nutrition

55(26.44)

153(73.56)

Normal and mild under nutrition

89(35.46)

162(64.54)

  1. Hint WHO-world health organization, NVP Nevirapine, EFV Efavirenz, DTG Dolutegravir, LPVr Lopinavir, ART antiretroviral therapy